XingImaging has been selected as the Imaging Core Lab for the Alzheimer's Tau Platform (ATP)--a groundbreaking, multi-arm, randomized Phase II clinical trial designed to simultaneously investigate ...
Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...
(RTTNews) - Boston Scientific Corp. (BSX) announced positive six-month results from the ongoing pivotal MODULAR ATP clinical trial of the mCRM System, the first modular cardiac rhythm management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results